Fermi Inc.
5.53USD
-0.1800 (-3.15%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.07▲ | $-0.09 | 0 | 1 |
| Next quarter | $-0.07▲ | $-0.1 | 0 | 0 |
| Current year | $-0.36▲ | $-0.41 | 0 | 1 |
| Next year | $0.12▼ | $0.36 | 0 | 0 |
Beat in 1 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.06 | $-0.04 | +0.02 (+33.6%) |
| 2026-03-31 | $-0.05 | $-0.3 | -0.25 (-508.6%) |
| 2025-12-31 | $-0.02 | $-0.18 | -0.16 (-951.4%) |
| 2025-09-30 | $-0.02 | $-0.84 | -0.82 (-3317.4%) |
18 ratings from 9 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Macquarie | Maintained | Outperform | $18 $15 | Aug 14, 2026 |
| Macquarie | Maintained | Outperform | $18 | Aug 13, 2026 |
| Mizuho | Maintained | Outperform | $27 $11 | Jul 28, 2026 |
| Stifel | Maintained | Buy | $29 $17 | Jun 23, 2026 |
| Evercore ISI Group | Downgraded from Outperform | In-Line | $20 $11 | May 15, 2026 |
| Macquarie | Maintained | Outperform | $20 | Apr 20, 2026 |
| Macquarie | Maintained | Outperform | $25 $20 | Apr 1, 2026 |
| UBS | Maintained | Buy | $30 $8 | Apr 1, 2026 |
| Macquarie | Maintained | Outperform | $25 | Feb 9, 2026 |
| Citizens | Initiated | Market Outperform | $30 | Feb 9, 2026 |
| Macquarie | Maintained | Outperform | $35 | Nov 12, 2025 |
| Macquarie | Initiated | Outperform | $35 | Oct 27, 2025 |
| UBS | Initiated | Buy | $30 | Oct 27, 2025 |
| Cantor Fitzgerald | Initiated | Overweight | $27 | Oct 27, 2025 |
| Berenberg | Initiated | Buy | $37 | Oct 27, 2025 |
| Stifel | Initiated | Buy | $29 | Oct 27, 2025 |
| Mizuho | Initiated | Outperform | $27 | Oct 27, 2025 |
| Rothschild & Co | Initiated | Buy | $31 | Oct 27, 2025 |
14 filings from 10 insiders · 9 buy / 5 sell over 6m
Officers and directors of FRMI, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| ORTIZ BLANES JACOBOChief Operating Officer | Grant | 147.1k | — | — | Aug 20, 2026 |
| MCINTIRE LEE AChief Executive Officer | Grant | 468.8k | — | — | Aug 14, 2026 |
| PERRY JAMES RICHARDDirector | Sell | 863.6k | $9.16 | $7.91M | Jun 30, 2026 |
| UZMAN MESUTOfficer | Sell | 158.5k | $6.31 | $1.00M | Jun 3, 2026 |
| MCINTIRE LEE ADirector | Grant | 175.1k | — | — | Jun 1, 2026 |
| HAAS MARIUS ADirector | Grant | 175.1k | — | — | Jun 1, 2026 |
| STEIN JEFFREY SCOTTDirector | Grant | 250.0k | — | — | Jun 1, 2026 |
| PERRY JAMES RICHARDDirector | Grant | 175.1k | — | — | Jun 1, 2026 |
| ROBBIN-COKER CORDELDirector | Grant | 175.1k | — | — | Jun 1, 2026 |
| KELLERMAN LAWRENCE MOfficer and Director | Grant | 35.8k | — | — | Jun 1, 2026 |
| EVERSON MILES E.Director | Grant | 35.8k | — | — | Jun 1, 2026 |
| EVERSON MILES E.Chief Financial Officer | Sell | 830.2k | $4.58 | $3.94M | Apr 9, 2026 |
| HAMILTON CHARLIEOfficer | Sell | 774.1k | $4.58 | $3.67M | Apr 9, 2026 |
| ORTIZ BLANES JACOBOChief Operating Officer | Sell | 830.9k | $4.58 | $3.94M | Apr 9, 2026 |
No analyst notes on FRMI yet.
Analyst Ratings
8 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 5 | 2 | 0 | 0 | Buy2.13 |
| 1 mo ago | 1 | 5 | 2 | 0 | 0 | Buy2.13 |
| 2 mo ago | 1 | 5 | 2 | 0 | 0 | Buy2.13 |